← FDA DRUG APPROVALS

FDA ANDA · ANDA078835

GRANISETRON HYDROCHLORIDE

Sponsor: SANDOZ INC

APPLICATION
ANDA078835
TYPE
ANDA
ORIGINAL APPROVAL
2008-06-30
LATEST ACTION
2015-07-15
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

GRANISETRON HYDROCHLORIDEPrescription
GRANISETRON HYDROCHLORIDE EQ 1MG BASE/ML (EQ 1MG BASE/ML) · INJECTABLE · INJECTION
GRANISETRON HYDROCHLORIDEPrescription
GRANISETRON HYDROCHLORIDE EQ 4MG BASE/4ML (EQ 1MG BASE/ML) · INJECTABLE · INJECTION

Approval history

2015-07-15Labeling · Supplement 13 · standardAP
2014-09-18Labeling · Supplement 12 · standardAP
2012-04-17Labeling · Supplement 8AP
2010-01-28Labeling · Supplement 6AP
2008-06-30OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →